ULTRAGENYX PHARMACEUTICAL IN

Ticker: RARE CUSIP: 90400D108 Class: EQTY

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 107,903 Value ($000) $2,420 Avg Close $32.88 Range $18.41 - $39.89

Q3 2025

Shares 67,035 Value ($000) $2,016 Avg Close $29.99 Range $25.81 - $42.37

Q2 2025

Shares 8,161 Value ($000) $297 Avg Close $36.05 Range $29.59 - $40.19

Q4 2024

Shares 35,201 Value ($000) $1,481 Avg Close $49.61 Range $41.26 - $57.99

Q3 2024

Shares 16,241 Value ($000) $902 Avg Close $50.94 Range $39.65 - $60.37

Q1 2024

Shares 9,077 Value ($000) $424 Avg Close $47.17 Range $41.87 - $54.56

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	107,903	$2,420	$32.88	$18.41 - $39.89
Q3 2025	67,035	$2,016	$29.99	$25.81 - $42.37
Q2 2025	8,161	$297	$36.05	$29.59 - $40.19
Q4 2024	35,201	$1,481	$49.61	$41.26 - $57.99
Q3 2024	16,241	$902	$50.94	$39.65 - $60.37
Q1 2024	9,077	$424	$47.17	$41.87 - $54.56